- Home
- CHGG vs KOD Comparison
CHGG vs KOD Comparison
Compare CHGG & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- KOD
- Stock Information
- Founded
- CHGG 2005
- KOD 2009
- Country
- CHGG United States
- KOD United States
- Employees
- CHGG N/A
- KOD N/A
- Industry
- CHGG Other Consumer Services
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHGG Real Estate
- KOD Health Care
- Exchange
- CHGG Nasdaq
- KOD Nasdaq
- Market Cap
- CHGG 179.9M
- KOD 186.3M
- IPO Year
- CHGG 2013
- KOD 2018
- Fundamental
- Price
- CHGG $1.72
- KOD $5.53
- Analyst Decision
- CHGG Hold
- KOD Hold
- Analyst Count
- CHGG 10
- KOD 5
- Target Price
- CHGG $4.75
- KOD $3.50
- AVG Volume (30 Days)
- CHGG 4.2M
- KOD 405.3K
- Earning Date
- CHGG 11-12-2024
- KOD 11-26-2024
- Dividend Yield
- CHGG N/A
- KOD N/A
- EPS Growth
- CHGG N/A
- KOD N/A
- EPS
- CHGG N/A
- KOD N/A
- Revenue
- CHGG $662,077,000.00
- KOD N/A
- Revenue This Year
- CHGG N/A
- KOD N/A
- Revenue Next Year
- CHGG N/A
- KOD N/A
- P/E Ratio
- CHGG N/A
- KOD N/A
- Revenue Growth
- CHGG N/A
- KOD N/A
- 52 Week Low
- CHGG $1.34
- KOD $2.08
- 52 Week High
- CHGG $11.48
- KOD $7.77
- Technical
- Relative Strength Index (RSI)
- CHGG 50.51
- KOD 77.30
- Support Level
- CHGG $1.34
- KOD $3.73
- Resistance Level
- CHGG $1.91
- KOD $5.39
- Average True Range (ATR)
- CHGG 0.14
- KOD 0.35
- MACD
- CHGG 0.01
- KOD 0.10
- Stochastic Oscillator
- CHGG 64.66
- KOD 86.77
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.